Envestnet Asset Management
ICCC icon

Envestnet Asset Management’s ImmuCell ICCC Stock Holding History

Envestnet Asset Management’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,202
Closed -$106K – 3714
2021
Q2 		$106K Hold
11,202
– – ﹤0.01% 3556
2021
Q1 		$108K Hold
11,202
– – ﹤0.01% 3416
2020
Q4 		$67K Buy
+11,202
New +$65.2K ﹤0.01% 3220

Other funds holding ICCC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFW
Meristem Family Wealth Minnetonka, Minnesota $925M AUM 14.15% 1-Year Est. Return
OMC
Overbrook Management Corp New York $663M AUM 35.04% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Envestnet Asset Management's ICCC Position: Q3 2021 in Review

Envestnet Asset Management sold out of ImmuCell (ICCC) in Q3 2021, closing a stake of 11,202 shares — an estimated $106K sold.

Envestnet Asset Management first reported a position in ICCC in Q4 2020 and held it in 3 quarters. The position peaked at $108K in Q1 2021. 28 funds tracked by Wall St. Rank hold ICCC as of Q3 2021.

  • Envestnet Asset Management reported no remaining ImmuCell position as of Q3 2021 after selling out during the quarter.
  • Envestnet Asset Management sold 11,202 ImmuCell shares in Q3 2021, an estimated $106K.
  • Envestnet Asset Management first reported a position in ImmuCell in Q4 2020 and held it in 3 quarters.
  • Envestnet Asset Management's ImmuCell position peaked at $108K in Q1 2021.
  • 28 funds tracked by Wall St. Rank held ImmuCell as of Q3 2021.

Based on Envestnet Asset Management's 13F filing for Q3 2021, filed 7 Oct 2021.